Evidence map›Paper›PMID 41155824›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Evaluation of TAM Receptor Targeting in Pathophysiology of Idiopathic Pulmonary Fibrosis.

Nicole Vercellino, Luciana L Ferreira, Elisa Zoppis, Alice Di Tizio, Zohre Sabihi Ahvaz, Rosalba Minisini, Francesco Gavelli, Pier Paolo Sainaghi, Filippo Patrucco, Mattia Bellan

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nicole VercellinoDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0009-0005-7453-2151
Luciana L FerreiraDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Elisa ZoppisDepartment of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
Alice Di TizioDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Zohre Sabihi AhvazDepartment of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
Rosalba MinisiniDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-7548-9731
Francesco GavelliDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-0581-245X
Pier Paolo SainaghiDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0001-8322-9158
Filippo PatruccoDivision of Respiratory Diseases, Medical Department, Maggiore della Carità University Hospital, 28100 Novara, Italy.ORCID 0000-0002-4794-8734
Mattia BellanDepartment of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0003-1488-8736

Funding

Fondazione Cariplo 2021-1541
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Idiopathic Pulmonary FibrosisProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesAxl Receptor Tyrosine KinaseBenzocycloheptenesCell MovementCell ProliferationCells, Culturedc-Mer Tyrosine KinaseFibroblastsGrowth Arrest-Specific Protein 6HumansIndolesIntercellular Signaling Peptides and ProteinsTriazolesAXL protein, humanAxl Receptor Tyrosine KinasebemcentinibBenzocycloheptenesc-Mer Tyrosine KinaseGrowth Arrest-Specific Protein 6IndolesIntercellular Signaling Peptides and ProteinsMERTK protein, humannintedanibProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesTriazolesBemcentinibfibrosisGas6Idiopathic Pulmonary Fibrosis (IPF)LDC1267nintedanibR428TAM receptorstherapeutic approaches

Identifiers

PMID41155824
PMCPMC12566192

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.